Dilution is never good. But after this raise would be equivalent to 50mill shares on offer at 90cents. for Nanabis phase 3 showing phase2 reduces chronic cancer pain by 40% is not a stab in the dark. And then there is phase2 depression trial which has a huge market that one. And then there is nanocelle platform that would work for any generic drug more efficient than tablets...
Dilution is never good. But after this raise would be equivalent...
Add to My Watchlist
What is My Watchlist?